MCRC
Clinical trials for MCRC explained in plain language.
Never miss a new study
Get alerted when new MCRC trials appear
Sign up with your email to follow new studies for MCRC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced colon cancer: drug cocktail plus radiation tested
Disease control Not yet recruitingThis study is for people with metastatic colorectal cancer that has spread to a few spots (like the liver or lungs) and hasn't responded to at least two prior treatments. It tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) plus targeted radiation to the…
Matched conditions: MCRC
Phase: PHASE2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 17, 2026 08:04 UTC
-
New cancer drug copycat faces off against erbitux in major trial
Disease control Not yet recruitingThis early-stage study tests whether a new drug called HLX05-N works as well as the standard drug Erbitux for people with metastatic colorectal cancer that has certain genetic features. About 387 adults will receive either HLX05-N or Erbitux along with chemotherapy. The goal is t…
Matched conditions: MCRC
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for advanced colon cancer: combo therapy targets tumors after standard treatment fails
Disease control Not yet recruitingThis study tests a new drug combination (SHR-1811 plus bevacizumab) as a second-line treatment for people with metastatic colorectal cancer that has worsened after initial chemotherapy. About 80 adults aged 18-75 will participate to see if the combo shrinks tumors or slows cancer…
Matched conditions: MCRC
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 01, 2026 15:57 UTC